F Boulad

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma
    F Boulad
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 16:1697-706. 1998
  2. ncbi Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study
    F Boulad
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 17:197-207. 1999
  3. ncbi Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts
    F Boulad
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Br J Haematol 111:1153-7. 2000
  4. ncbi Gene therapy for homozygous beta-thalassemia. Is it a reality?
    Farid Boulad
    Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Hemoglobin 33:S188-96. 2009
  5. ncbi Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions
    T N Small
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Blood 93:467-80. 1999
  6. ncbi Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT
    M A Perales
    Allogeneic Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Bone Marrow Transplant 45:1408-16. 2010
  7. ncbi Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria
    D J Araten
    Department of Human Genetics, Memorial Sloan-Kettering Cancer Center, New York, USA
    Br J Haematol 115:360-8. 2001
  8. ncbi Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation
    W Chemaitilly
    Department of Pediatrics, New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY, USA
    Bone Marrow Transplant 40:29-35. 2007
  9. ncbi Disorders of glucose homeostasis in young adults treated with total body irradiation during childhood: a pilot study
    W Chemaitilly
    Department of Pediatric Endocrinology, New York Presbyterian Hospital Weill Cornell Medical College and Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Bone Marrow Transplant 44:339-43. 2009
  10. ncbi Lung transplantation after allogeneic marrow transplantation in pediatric patients: the Memorial Sloan-Kettering experience
    J A Heath
    Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    Transplantation 72:1986-90. 2001

Collaborators

Detail Information

Publications16

  1. ncbi High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma
    F Boulad
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 16:1697-706. 1998
    ..Consolidation was with intensive chemotherapy and autologous bone marrow transplantation (ABMT)...
  2. ncbi Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study
    F Boulad
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 17:197-207. 1999
    ....
  3. ncbi Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts
    F Boulad
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Br J Haematol 111:1153-7. 2000
    ..Both patients experienced minimal toxicity, rapid engraftment and no GVHD...
  4. ncbi Gene therapy for homozygous beta-thalassemia. Is it a reality?
    Farid Boulad
    Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Hemoglobin 33:S188-96. 2009
    ..The protocol will be offered to patients with transfusion-dependent ss-thalassemia who are 15 years or older and lack a matched, related donor...
  5. ncbi Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions
    T N Small
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Blood 93:467-80. 1999
    ....
  6. ncbi Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT
    M A Perales
    Allogeneic Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Bone Marrow Transplant 45:1408-16. 2010
    ..Furthermore, the sAAIPI can predict outcomes and may be used to select the most appropriate patients for this type of transplant...
  7. ncbi Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria
    D J Araten
    Department of Human Genetics, Memorial Sloan-Kettering Cancer Center, New York, USA
    Br J Haematol 115:360-8. 2001
    ..However, none of our patients developed excess blasts or leukaemia. We conclude that in patients with PNH cytogenetically abnormal clones are not necessarily malignant and may not be predictive of evolution to leukaemia...
  8. ncbi Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation
    W Chemaitilly
    Department of Pediatrics, New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY, USA
    Bone Marrow Transplant 40:29-35. 2007
    ..Final height after hyperfractionated TBI was similar to that reported after fractionated TBI...
  9. ncbi Disorders of glucose homeostasis in young adults treated with total body irradiation during childhood: a pilot study
    W Chemaitilly
    Department of Pediatric Endocrinology, New York Presbyterian Hospital Weill Cornell Medical College and Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Bone Marrow Transplant 44:339-43. 2009
    ..Insulin resistance is frequently observed in adult survivors of HSCT treated with TBI in childhood. Underlying mechanisms may include radiation-induced growth hormone deficiency and changes in body composition...
  10. ncbi Lung transplantation after allogeneic marrow transplantation in pediatric patients: the Memorial Sloan-Kettering experience
    J A Heath
    Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA
    Transplantation 72:1986-90. 2001
    ..CONCLUSION: We conclude that lung transplantation offers a viable therapeutic option for patients who develop respiratory failure secondary to BMT...
  11. ncbi Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults
    B H Kushner
    Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Bone Marrow Transplant 28:551-6. 2001
    ....
  12. ncbi Cytomegalovirus ventriculoencephalitis in a bone marrow transplant recipient receiving antiviral maintenance: clinical and molecular evidence of drug resistance
    S K Seo
    Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    Clin Infect Dis 33:e105-8. 2001
    ..Analysis of sequential viral isolates recovered from the patient's cerebrospinal fluid suggested that disease developed because of the presence of viral resistance and, possibly, low tissue penetration of antiviral agents...
  13. ncbi Respiratory syncytial virus infection following hematopoietic stem cell transplantation
    T N Small
    Department of Pediatrics, Bone Marrow Transplant Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Bone Marrow Transplant 29:321-7. 2002
    ..In this aggressively treated patient population, three patients died of RSV disease, each following an unrelated HSCT...
  14. ncbi Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease
    M A Perales
    Allogeneic Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Bone Marrow Transplant 40:481-6. 2007
    ..Careful patient selection and aggressive prophylaxis against viral and fungal infections are recommended...
  15. ncbi Endocrine complications of pediatric stem cell transplantation
    C Sklar
    Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, NY, NY 10021, USA
    Front Biosci 6:G17-22. 2001
    ..Leydig cell function, however, is retained in most males treated with standard forms of cytoreduction. Many patients demonstrate reduced bone mineral density and are at risk of developing osteoporosis in the future...
  16. ncbi Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH): no evidence for intrinsic growth advantage of PNH clones
    D J Araten
    Department of Medicine, Hematology Division, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    Leukemia 16:2243-8. 2002
    ..In addition, since in most cases no further expansion takes place, we can infer that the tendency to overgrow normal cells is not an intrinsic property of the PNH clone...